Global High Throughput Screening (HTS) Markets 2021-2027: Resolving Technical Limitations - The Cornerstone for Future Success of Cell-based HTS
Dublin, Aug. 19, 2021 (GLOBE NEWSWIRE) -- The "High Throughput Screening (HTS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global High Throughput Screening (HTS) Market to Reach $22.7 Billion by 2027
Amid the COVID-19 crisis, the global market for High Throughput Screening (HTS) estimated at US$14.5 Billion in the year 2020, is projected to reach a revised size of US$22.7 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027.
Consumables/Reagents, one of the segments analyzed in the report, is projected to record a 7.1% CAGR and reach US$13.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 10.1% CAGR
The High Throughput Screening (HTS) market in the U.S. is estimated at US$3.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.
Software & Services Segment to Record 5.4% CAGR
In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$2.7 Billion by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027, while Latin America will expand at a 6.6% CAGR through the analysis period.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
High Throughput Screening (HTS): A Prelude
Recent Market Activity
HTS: The Mainstream Technology for Drug Discovery Programs
Unparalleled Advantages in Compound Screening Drives Wider Adoption
Key Benefits of HTS - An Overview
Soaring R&D Spending Creates Conducive Environment for HTS
Shift towards High Throughput Research Builds Momentum for HTS
Upward Trajectory in Med Tech Sector Generates Parallel Opportunities
Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term
Developed Regions: Key Revenue Contributors
HTS Adoption Continues to Expand in Developing Regions
Key Factors Driving Demand for HTS in the Developing Regions
Competitive Scenario
Leading Players in the World HTS Market
M&A Activity
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 104 Featured)
Agilent Technologies, Inc. (USA)
Aurora Biomed, Inc. (Canada)
Axxam SpA (Italy)
BD Biosciences (USA)
Danaher Corporation (USA)
Beckman Coulter, Inc. (USA)
Molecular Devices Inc. (USA)
Pall ForteBio LLC (USA)
Bio-Rad Laboratories, Inc. (USA)
BioTek Instruments Inc. (USA)
BMG LABTECH GmbH (Germany)
Charles River Laboratories International, Inc. (USA)
Corning Inc. (USA)
DiscoveRx Corporation (USA)
Evotec AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genedata AG (Switzerland)
IntelliCyt Corporation (USA)
Luminex Corporation (USA)
PerkinElmer, Inc. (USA)
Sigma-Aldrich Corp. (USA)
Tecan Group Ltd. (Switzerland)
Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
Cell-based Assay: The Widely Used HTS Technology
Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
HTS Aims to Expand Use Case in Biochemical Applications
Label-Free HTS Demonstrates Fastest Growth
Lab-on-a-Chip HTS Seeks to Proliferate the Market
Bioinformatics HTS Enhanced with Computational Algorithms
Positive Prognosis across End-Use Markets to Underpin Revenue Growth
Pharmaceutical Industry Leads the Way
HTS Deployments Soar in Academia
Progressive Advancements in HTS Instruments Accelerate Market Growth
Microplate Handling Systems: An Important HTS Instrument Type
Liquid Handling Devices: A Necessity in HTS Processes
Microscopic Systems Facilitate Seamless Quantitative Analysis
Advanced Software Platforms Augment HTS Proficiency
Services: An Important Revenue Generating Segment
Expansion in Compound Libraries Widens Functional Scope of HTS
Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis
Laboratory Automation & Miniaturization Spell Opportunities for HTS
Miniaturization of Compound Screening Processes Drives Demand for HTS
HTS Miniaturization - Technology Developments
HTS Robotics Support Miniaturization
IVC - A Miniaturized, Powerful HTS Technology
HTS Assumes Critical Importance in Target Identification & Validation
HTS Gathers Steam in Primary Screening Applications
HTS Perceives Bright Future in Stem Cell Research
HTS in Kinase Inhibitors Identification
HTS in Alzheimer's Disease Drug Discovery
HTS for Less Simplified PCR Systems
HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs
Open Access Platforms Widen HTS Audience Base
Need for Stringent QA System to Keep Failures at Bay
High Throughput Screening (HTS) Vs. High Content Screening (HCS)
Rise in Adoption of HCS Technology in HTS Laboratories
4. GLOBAL MARKET PERSPECTIVE
United States
Canada
Japan
China
Europe
France
Germany
Italy
United Kingdom
Rest Of Europe
Asia-Pacific
Rest Of World
III. MARKET ANALYSIS
IV. COMPETITION
Total Companies Profiled: 104
For more information about this report visit https://www.researchandmarkets.com/r/1gdseg
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900